Variant · Snv
RET NM_020975.6(RET):c.3112A>G (p.Thr1038Ala)
CI-VAR-00022096Explore in graph →p.Thr1038AlaNM_020975.6:c.3112A>GClinVar 136115 rs201740483
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 136115 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications | 1 | Hereditary cancer-predisposing syndrome; Multiple endocrine neoplasia type 2A; Ewing sarcoma of soft tissue; Multiple endocrine neoplasia, type 2; Hirschsprung disease, susceptibility to, 1; Renal hypodysplasia/aplasia 1; Pheochromocytoma; Multiple endocrine neoplasia; RET-related disorder | germline | 21 | Feb 03, 2026 | clinvar |